NBTX
Nanobiotix S.A.
Price Chart
Latest Quote
$36.60
+1.37 (+3.89%)
Current Price
| Previous Close | $35.23 |
| Open | $34.38 |
| Day High | $37.08 |
| Day Low | $34.38 |
| Volume | 124,505 |
Stock Information
Note: Financial values converted from EUR to USD
| Shares Outstanding | 50.79M |
| Total Debt | $108.26M |
| Cash Equivalents | $59.91M |
| Revenue | $37.02M |
| Net Income | $-27.21M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $1.86B |
| EPS (TTM) | $-0.57 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.81B |
| Sales | $37.02M |
| Income | $-27.21M |
| Book/sh | $-2.03 |
| Cash/sh | $1.04 |
| Employees | 100 |
Financial Ratios
| Quick Ratio | 1.05 |
| Current Ratio | 1.09 |
Returns & Margins
| ROA | -10.06% |
| Gross Margin | 100.00% |
| Operating Margin | -196.42% |
| Profit Margin | -73.52% |
Ownership
| Institutional Ownership | 11.76% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 473.69 |
| P/S | 57.03 |
| P/B | -18.07 |
Analyst Data
| Recommendation | none |
| Target Price | $43.30 |
Technical Indicators
| SMA20 | $36.82 |
| SMA50 | $38.14 |
| SMA200 | $26.77 |
| RSI | 49.46 |
| ATR | 2.8188 |
| Shares Float | 31.82M |
| Short Float | 0.09% |
| Short Ratio | 0.37 |
| Volatility | 0.59 |
| Rel Volume | 1.92 |
Performance History
| Week | -1.40% |
| Month | -8.91% |
| Quarter | +19.84% |
| 6 Months | +65.61% |
| YTD | +65.39% |
| Year | +718.79% |
| 3 Years | +613.45% |
| 5 Years | +136.43% |
| 10 Years | +115.55% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $36.60 | 124,500 |
| 2026-06-22 | $35.23 | 97,100 |
| 2026-06-18 | $36.27 | 49,600 |
| 2026-06-17 | $36.07 | 74,200 |
| 2026-06-16 | $35.99 | 64,400 |
| 2026-06-15 | $37.12 | 119,000 |
| 2026-06-12 | $35.54 | 84,300 |
| 2026-06-11 | $35.33 | 84,400 |
| 2026-06-10 | $33.55 | 77,400 |
| 2026-06-09 | $34.34 | 109,500 |
| 2026-06-08 | $35.88 | 26,000 |
| 2026-06-05 | $35.46 | 49,600 |
| 2026-06-04 | $36.91 | 19,800 |
| 2026-06-03 | $35.20 | 49,300 |
| 2026-06-02 | $36.76 | 53,900 |
| 2026-06-01 | $38.00 | 54,500 |
| 2026-05-29 | $40.40 | 39,200 |
| 2026-05-28 | $40.41 | 20,100 |
| 2026-05-27 | $40.50 | 26,700 |
| 2026-05-26 | $40.80 | 70,700 |
About Nanobiotix S.A.
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
đ° Latest News
Nanobiotix (NBTX) Provides Update on Operational Progress
Insider Monkey âĸ 2026-06-22T12:47:31Z
Nanobiotix Equity Raise Backs JNJ-1900 Progress And Volatile Share Rally
Simply Wall St. âĸ 2026-05-30T22:04:06Z
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Amid Uncertainty Surrounding US-Iran Talks
MT Newswires âĸ 2026-05-21T13:18:35ZHow Nanobiotix Got Wall Street's Attention By Using Physics To Battle Cancer
Investor's Business Daily âĸ 2026-05-20T12:00:49Z
Assessing Nanobiotix (ENXTPA:NANO) Valuation After Strong Recent Share Price Momentum
Simply Wall St. âĸ 2026-04-27T11:08:21Z
Nanobiotix H2 Earnings Call Highlights
MarketBeat âĸ 2026-04-01T15:20:17Z
Sector Update: Health Care Stocks Gain Late Afternoon
MT Newswires âĸ 2026-03-25T19:49:48ZNanobiotix (ENXTPA:NANO): Assessing Valuation After a Powerful MultiâMonth Share Price Surge
Simply Wall St. âĸ 2025-12-08T07:06:19Z
Biotech Stock Nanobiotix (NBTX) Is Up 660% This Year -- Here's Why the Rally Could Continue
Motley Fool âĸ 2025-11-24T15:29:00Z
Nanobiotix (ENXTPA:NANO): Evaluating Valuation After $71 Million Royalty Deal Expands Growth Prospects
Simply Wall St. âĸ 2025-11-13T16:09:42Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $33,986,470 | $-13,311,167 | $34,462,279 | $0 |
| Operating Revenue | $26,005,503 | $-20,103,187 | $34,109,148 | $0 |
| Expenses | ||||
| Interest Expense | $11,918,138 | $9,270,809 | $9,151,571 | $6,692,272 |
| Total Expenses | $46,389,588 | $65,102,039 | $65,163,952 | $53,546,204 |
| Other Income Expense | $-3,707,865 | $3,422,380 | $-7,248,337 | $2,414,584 |
| Net Non Operating Interest Income Expense | $-11,357,487 | $-3,009,631 | $-7,429,488 | $-14,258,197 |
| Total Other Finance Cost | $568,677 | $-3,246,962 | $-326,760 | $7,859,436 |
| Interest Expense Non Operating | $11,918,138 | $9,270,809 | $9,151,571 | $6,692,272 |
| Operating Expense | $46,389,588 | $65,102,039 | $65,163,952 | $53,546,204 |
| Other Operating Expenses | $-463,197 | $-959,642 | $513,644 | $393,258 |
| General And Administrative Expense | $23,185,049 | $22,998,165 | $24,834,900 | $20,041,274 |
| Rent Expense Supplemental | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-27,471,909 | $-78,115,109 | $-45,517,082 | $-65,398,990 |
| Net Interest Income | $-11,357,487 | $-3,009,631 | $-7,429,488 | $-14,258,197 |
| Interest Income | $1,129,328 | $3,014,217 | $1,395,322 | $293,511 |
| Normalized Income | $-24,691,011 | $-80,681,895 | $-40,080,829 | $-67,209,927 |
| Net Income From Continuing And Discontinued Operation | $-27,471,909 | $-78,115,109 | $-45,517,082 | $-65,398,990 |
| Total Operating Income As Reported | $2,398,532 | $-78,413,206 | $-30,702,820 | $-53,545,057 |
| Net Income Common Stockholders | $-27,471,909 | $-78,115,109 | $-45,517,082 | $-65,398,990 |
| Net Income | $-27,471,909 | $-78,115,109 | $-45,517,082 | $-65,398,990 |
| Net Income Including Noncontrolling Interests | $-27,471,909 | $-78,116,256 | $-45,517,082 | $-65,401,283 |
| Net Income Continuous Operations | $-27,471,909 | $-78,116,256 | $-45,517,082 | $-65,401,283 |
| Pretax Income | $-27,468,470 | $-78,000,457 | $-45,379,499 | $-65,389,817 |
| Interest Income Non Operating | $1,129,328 | $3,014,217 | $1,395,322 | $293,511 |
| Operating Income | $-12,403,118 | $-78,413,206 | $-30,701,673 | $-53,546,204 |
| Depreciation Amortization Depletion Income Statement | $395,551 | $365,742 | $309,562 | $384,086 |
| Depreciation And Amortization In Income Statement | $395,551 | $365,742 | $309,562 | $384,086 |
| Amortization Of Intangibles Income Statement | $1,147 | $1,147 | $0 | $1,147 |
| Depreciation Income Statement | $394,405 | $364,595 | $309,562 | $382,940 |
| Special Income Charges | - | - | $0 | $0 |
| Per Share | ||||
| Diluted EPS | $-0.57 | $-1.65 | $-1.24 | $-1.88 |
| Basic EPS | $-0.57 | $-1.65 | $-1.24 | $-1.88 |
| Other | ||||
| Tax Effect Of Unusual Items | $-926,966 | $855,595 | $-1,812,084 | $603,646 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-10,128,411 | $-70,293,509 | $-27,244,897 | $-59,392,340 |
| Total Unusual Items | $-3,707,865 | $3,422,380 | $-7,248,337 | $2,414,584 |
| Total Unusual Items Excluding Goodwill | $-3,707,865 | $3,422,380 | $-7,248,337 | $2,414,584 |
| Reconciled Depreciation | $1,714,056 | $1,858,519 | $1,734,694 | $1,719,789 |
| EBITDA (Bullshit earnings) | $-13,836,276 | $-66,871,129 | $-34,493,235 | $-56,977,756 |
| EBIT | $-15,550,332 | $-68,729,648 | $-36,227,929 | $-58,697,545 |
| Diluted Average Shares | $54,826,446 | $54,190,768 | $42,339,097 | $39,877,433 |
| Basic Average Shares | $54,826,446 | $54,190,768 | $42,339,097 | $39,877,433 |
| Diluted NI Availto Com Stockholders | $-27,471,909 | $-78,115,109 | $-45,517,082 | $-65,398,990 |
| Tax Provision | $3,440 | $115,799 | $137,583 | $11,465 |
| Gain On Sale Of Security | $-3,707,865 | $3,422,380 | $-7,248,337 | $2,414,584 |
| Other Taxes | $-3,229,764 | $-3,783,536 | $-4,516,166 | $-4,690,438 |
| Amortization | $1,147 | $1,147 | $0 | $1,147 |
| Research And Development | $26,501,948 | $46,481,311 | $44,022,012 | $37,418,023 |
| Selling General And Administration | $23,185,049 | $22,998,165 | $24,834,900 | $20,041,274 |
| Other Gand A | $9,167,622 | $9,255,904 | $11,337,996 | $8,933,731 |
| Salaries And Wages | $14,017,427 | $13,742,261 | $13,496,904 | $11,107,544 |
| Rent And Landing Fees | - | - | - | - |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-96,873,421 | $-75,338,223 | $-2,123,366 | $-31,008,942 |
| Total Assets | $77,688,602 | $77,296,490 | $107,655,352 | $68,526,712 |
| Total Non Current Assets | $5,744,095 | $6,822,976 | $7,518,918 | $8,498,051 |
| Other Non Current Assets | $28,663 | - | - | - |
| Non Current Prepaid Assets | $468,929 | $465,490 | $342,811 | $333,639 |
| Goodwill And Other Intangible Assets | $11,465 | $8,026 | $9,172 | $1,147 |
| Other Intangible Assets | $11,465 | $8,026 | $9,172 | $1,147 |
| Current Assets | $71,944,506 | $70,472,367 | $100,136,434 | $60,029,808 |
| Other Current Assets | $2,293 | $-1,147 | $1,147 | $1,147 |
| Prepaid Assets | $2,657,647 | $3,663,151 | $2,935,107 | $3,417,794 |
| Receivables | $8,805,320 | $9,785,599 | $10,886,264 | $9,158,450 |
| Other Receivables | $1,634,946 | $1,243,981 | $3,989,910 | $3,142,628 |
| Taxes Receivable | $4,721,394 | $5,128,411 | $5,858,748 | $5,900,023 |
| Accounts Receivable | $2,448,980 | $3,413,208 | $1,037,606 | $115,799 |
| Cash Cash Equivalents And Short Term Investments | $60,479,246 | $57,024,764 | $86,313,917 | $47,452,418 |
| Cash And Cash Equivalents | $60,479,246 | $57,024,764 | $86,313,917 | $47,452,418 |
| Cash Equivalents | $59,550,560 | $50,936,711 | $0 | $3,225,178 |
| Cash Financial | $928,686 | $6,086,907 | $86,313,917 | $44,228,387 |
| Investmentin Financial Assets | - | - | $0 | $0 |
| Debt | ||||
| Net Debt | $45,253,381 | - | - | $7,165,788 |
| Total Debt | $109,285,712 | $58,360,466 | $57,974,087 | $60,958,494 |
| Long Term Debt And Capital Lease Obligation | $104,345,331 | $52,714,972 | $52,216,234 | $55,730,336 |
| Long Term Debt | $102,179,544 | $49,310,937 | $47,764,273 | $50,493,005 |
| Current Debt And Capital Lease Obligation | $4,940,381 | $5,645,494 | $5,757,854 | $5,228,159 |
| Current Debt | $3,553,084 | $4,199,725 | $4,383,169 | $4,125,201 |
| Other Current Borrowings | $3,553,084 | $4,199,725 | $4,383,169 | $4,125,201 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $174,550,558 | $152,626,688 | $109,769,546 | $99,534,508 |
| Total Non Current Liabilities Net Minority Interest | $108,617,287 | $85,056,178 | $52,588,855 | $56,039,898 |
| Other Non Current Liabilities | $3,690,667 | $31,845,906 | $2,293 | - |
| Current Liabilities | $65,933,271 | $67,570,510 | $57,180,691 | $43,494,610 |
| Other Current Liabilities | $357,716 | $8,983,031 | - | - |
| Current Deferred Liabilities | $41,523,732 | $20,822,059 | $20,898,876 | $19,001,375 |
| Payables And Accrued Expenses | $18,976,152 | $31,617,748 | $29,652,602 | $18,890,162 |
| Payables | $16,062,829 | $13,789,268 | $16,617,748 | $12,705,801 |
| Other Payable | $702,820 | $770,465 | $481,541 | $559,505 |
| Total Tax Payable | $7,815,868 | $7,877,780 | $8,460,215 | $7,561,339 |
| Accounts Payable | $7,544,141 | $5,141,023 | $7,675,992 | $4,584,957 |
| Equity | ||||
| Common Stock Equity | $-96,861,956 | $-75,330,198 | $-2,114,194 | $-31,007,796 |
| Total Equity Gross Minority Interest | $-96,861,956 | $-75,330,198 | $-2,114,194 | $-31,007,796 |
| Stockholders Equity | $-96,861,956 | $-75,330,198 | $-2,114,194 | $-31,007,796 |
| Gains Losses Not Affecting Retained Earnings | $-431,260,022 | $-357,153,168 | $-316,523,726 | $-259,782,154 |
| Other Equity Adjustments | $-431,260,022 | $-357,153,168 | $-316,523,726 | $-259,782,154 |
| Retained Earnings | $-27,471,909 | $-78,115,109 | $-45,517,082 | $-65,398,990 |
| Other | ||||
| Treasury Shares Number | $25,359 | $25,359 | $25,359 | $25,359 |
| Ordinary Shares Number | $55,478,043 | $54,350,759 | $54,014,227 | $39,960,735 |
| Share Issued | $55,503,402 | $54,376,118 | $54,039,586 | $39,986,094 |
| Tangible Book Value | $-96,873,421 | $-75,338,223 | $-2,123,366 | $-31,008,942 |
| Invested Capital | $8,870,672 | $-21,819,536 | $50,033,248 | $23,610,410 |
| Working Capital | $6,011,236 | $2,901,857 | $42,955,743 | $16,535,198 |
| Capital Lease Obligations | $3,553,084 | $4,849,805 | $5,826,645 | $6,340,289 |
| Total Capitalization | $5,317,588 | $-26,019,261 | $45,650,079 | $19,485,209 |
| Treasury Stock | $261,408 | $261,408 | $261,408 | $261,408 |
| Additional Paid In Capital | $360,466,628 | $358,567,981 | $358,566,834 | $293,235,490 |
| Capital Stock | $1,664,756 | $1,631,506 | $1,621,188 | $1,199,266 |
| Common Stock | $1,664,756 | $1,631,506 | $1,621,188 | $1,199,266 |
| Employee Benefits | $581,289 | $495,299 | $370,328 | $309,562 |
| Non Current Pension And Other Postretirement Benefit Plans | $581,289 | $495,299 | $370,328 | $309,562 |
| Long Term Capital Lease Obligation | $2,165,788 | $3,404,036 | $4,451,960 | $5,237,331 |
| Current Deferred Revenue | $41,523,732 | $20,822,059 | $20,898,876 | $19,001,375 |
| Current Capital Lease Obligation | $1,387,296 | $1,445,769 | $1,374,685 | $1,102,958 |
| Current Provisions | $135,290 | $502,178 | $871,360 | $374,914 |
| Current Accrued Expenses | $2,913,323 | $17,828,479 | $13,034,854 | $6,184,361 |
| Net PPE | $5,235,038 | $6,349,461 | $7,166,934 | $8,163,265 |
| Accumulated Depreciation | $-14,263,930 | $-12,635,863 | $-10,847,282 | $-9,378,583 |
| Gross PPE | $19,498,968 | $18,985,324 | $18,014,217 | $17,541,848 |
| Construction In Progress | $734,923 | $448,292 | $215,547 | $394,405 |
| Other Properties | $2,968,356 | $2,859,436 | $2,669,113 | $2,438,661 |
| Machinery Furniture Equipment | $5,400,137 | $5,329,053 | $5,042,421 | $5,005,733 |
| Buildings And Improvements | $10,395,551 | $10,348,544 | $10,087,136 | $9,701,903 |
| Properties | $0 | $0 | $0 | $0 |
| Investments And Advances | - | - | $0 | $0 |
| Available For Sale Securities | - | - | - | - |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-38,945,195 | $-23,387,984 | $-14,690,438 | $-42,646,181 |
| Operating Activities | ||||
| Operating Cash Flow | $-38,319,192 | $-22,415,730 | $-14,304,058 | $-42,539,554 |
| Cash Flow From Continuing Operating Activities | $-38,318,045 | $-22,415,730 | $-14,305,205 | $-42,541,847 |
| Operating Gains Losses | $175,418 | $-3,440 | $-27,517 | $3,440 |
| Investing Activities | ||||
| Capital Expenditure | $-626,003 | $-972,254 | $-386,379 | $-106,627 |
| Investing Cash Flow | $-662,692 | $-1,094,932 | $-400,138 | $158,221 |
| Cash Flow From Continuing Investing Activities | $-662,692 | $-1,094,932 | $-400,138 | $157,074 |
| Net Other Investing Changes | - | - | - | $1,147 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $1,759,917 | $0 | $68,968,125 | $0 |
| Financing Cash Flow | $42,898,417 | $-5,887,411 | $53,624,168 | $-6,479,018 |
| Cash Flow From Continuing Financing Activities | $42,899,563 | $-5,887,411 | $53,624,168 | $-6,477,872 |
| Net Other Financing Charges | $-891,997 | - | $-3,198,808 | $-1,147 |
| Cash Dividends Paid | $0 | $0 | $0 | $0 |
| Net Common Stock Issuance | $1,759,917 | $0 | $68,968,125 | $0 |
| Common Stock Issuance | $1,759,917 | $0 | $68,968,125 | $0 |
| Other | ||||
| Repayment Of Debt | $-5,439,119 | $-4,763,816 | $-4,316,670 | $-5,428,801 |
| Issuance Of Debt | $49,223,801 | $0 | $171,979 | $0 |
| End Cash Position | $60,479,246 | $57,024,764 | $86,313,917 | $47,452,418 |
| Beginning Cash Position | $57,024,764 | $86,313,917 | $47,452,418 | $96,217,608 |
| Effect Of Exchange Rate Changes | $-460,903 | $107,773 | $-58,473 | $95,162 |
| Changes In Cash | $3,915,386 | $-29,396,927 | $38,919,972 | $-48,860,352 |
| Interest Paid Cff | $-1,754,185 | $-1,123,595 | $-8,000,458 | $-1,049,071 |
| Net Issuance Payments Of Debt | $43,784,681 | $-4,763,816 | $-4,144,691 | $-5,428,801 |
| Net Long Term Debt Issuance | $43,784,681 | $-4,763,816 | $-4,144,691 | $-5,428,801 |
| Long Term Debt Payments | $-5,439,119 | $-4,763,816 | $-4,316,670 | $-5,428,801 |
| Long Term Debt Issuance | $49,223,801 | $0 | $171,979 | $0 |
| Net Investment Purchase And Sale | $-36,689 | $-122,678 | $-13,758 | $263,701 |
| Net Intangibles Purchase And Sale | $-9,172 | $-2,293 | $-10,319 | $-1,147 |
| Purchase Of Intangibles | $-9,172 | $-2,293 | $-10,319 | $-1,147 |
| Net PPE Purchase And Sale | $-616,831 | $-969,961 | $-376,061 | $-105,480 |
| Purchase Of PPE | $-616,831 | $-969,961 | $-376,061 | $-105,480 |
| Taxes Refund Paid | $-227,012 | $-71,085 | $-8,026 | $0 |
| Change In Working Capital | $-3,899,335 | $16,375,831 | $11,373,538 | $2,635,863 |
| Change In Other Working Capital | $-18,344 | $13,979,592 | $1,848,200 | - |
| Change In Other Current Liabilities | $200,642 | $-256,822 | $828,938 | $1,398,762 |
| Change In Payables And Accrued Expense | $-6,203,852 | $2,246,044 | $9,946,113 | $3,330,658 |
| Change In Payable | $-6,203,852 | $2,246,044 | $9,946,113 | $3,330,658 |
| Change In Receivables | $2,122,220 | $407,017 | $-1,249,713 | $-2,093,556 |
| Changes In Account Receivables | $963,082 | $-2,373,309 | $-924,100 | $-115,799 |
| Other Non Cash Items | $-12,413,437 | $32,797,523 | $13,728,502 | $14,511,580 |
| Stock Based Compensation | $4,057,556 | $4,927,769 | $3,694,107 | $3,639,074 |
| Provisionand Write Offof Assets | $-257,968 | $-301,536 | $580,142 | $349,690 |
| Deferred Tax | $3,440 | $115,799 | $137,583 | $0 |
| Deferred Income Tax | $3,440 | $115,799 | $137,583 | $0 |
| Depreciation Amortization Depletion | $1,714,056 | $1,858,519 | $1,734,694 | $1,719,789 |
| Depreciation And Amortization | $1,714,056 | $1,858,519 | $1,734,694 | $1,719,789 |
| Net Income From Continuing Operations | $-27,471,909 | $-78,115,109 | $-45,517,082 | $-65,398,990 |
| Proceeds From Stock Option Exercised | - | - | $0 | $0 |
| Purchase Of Investment | - | - | - | - |
Fetched: 2026-06-18